Insider trades
Christobel Selecky, Director of ImmunityBio IBRX, has filed 0 purchases and 3 sales on the open market. Over the past 12 months that comes to a net sale of $687.8K. The latest trade was on 06/09.
Christobel Selecky
Director
- Company
- ImmunityBio IBRX
- First filing
- 23/06/15
- Trades
- 13 trades
- Buys / sales
- 0 / 3
- 12-month net buying
- −$687.8K
- Last trade
- 06/09
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
ImmunityBioIBRX | Open-market sale10b5-1 plan | 02/23 | 02/24 | 25,000 sh | $10.00 | $250,000 | −100.0% |
IBRX | Open-market sale10b5-1 plan | 01/16–01/20 | 01/21 | 75,000 sh2 trades | $5.84avg. | $437,750 | −100.0% |